No phaseCompletedGeroscience intervention
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels: A Double-Blind Parallel Trial
- Sponsor
- Qualia Life Sciences (Industry)
- Enrolment
- 170 enrolled
- Conditions
- NAD+ Levels in the Blood
- Interventions
- Qualia NAD+; Placebo
- Ages
- adults, older adults
- Registry
- NCT06505967
Full record on ClinicalTrials.gov
From the registry
The goal of this clinical trial is to determine if Qualia NAD+ effectively increases NAD+ levels in the blood and to evaluate its safety. Researchers will compare Qualia NAD+ to a placebo (a look-alike substance that contains no active drug) to assess its efficacy in increasing NAD+ levels in the blood. Participants will: Take Qualia NAD+ or a placebo every day for 4 weeks. Undergo blood tests before and after the trial.
Primary outcomes
- NAD+ Levels in the Blood
History
Last registry update
Study completion
Primary completion
Registered
Started